Abstract
The implementation, management, and reporting of any single well-designed cancer clinical trial is an extremely complex and expensive undertaking. However, within our group, there is the opportunity to simultaneously design, implement, monitor, and analyze up to approximately 100 publicly funded clinical trials across the development spectrum. Operationally, we aggressively seek to optimize and standardize processes and software that are common across studies, increase efficiency, and focus on the quality and reliability of study results. Implementing novel software applications increases the quality and efficiency of data evaluation, monitoring, and statistical analysis across multiple disease and study types. Conventions and cross-study tools are the key to quality monitoring and analysis of complex portfolio of studies. A strategy of fully utilizing the commonalities across the trials leads to better quality results of any given study in the portfolio as well as more efficient utilization of public funds to conduct the studies.
In this chapter the structure and processes are described in the context of SWOG Cancer Research Network, one of the four National Clinical Trial Network (NCTN) adult cancer clinical trial groups funded by the US National Institutes of Health (NIH) under a cooperative agreement with the US National Cancer Institute (NCI).
References
Fleming TR, Harrington DP, O’Brien PC (1984) Designs for group sequential tests. Control Clin Trials 5(4):348–361
Freidlin B, Othus M, Korn EL (2016) Information time scales for interim analyses of randomized clinical trials. Clin Trials 13(4):391–399. https://doi.org/10.1177/1740774516644752. PMID 27136947
Gentleman R, Temple Lang D (2007) Statistical analyses and reproducible research. J Comput Graph Stat 16:1–23. https://doi.org/10.1198/106186007X178663
Green S, Benedetti J, Smith A, Crowley J (2016) Clinical trials in oncology, 3rd edn. CRC Press, Boca Raton
Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis J (2016) Reproducible research practices and transparency across the biomedical literature. PLoS Biol 14(1):e1002333. https://doi.org/10.1371/journal.pbio.1002333. PMID: 26726926. PMCID: PMC4699702
NCI Community Oncology Research Program (NCORP). www.cancer.gov/research/areas/clinical-trials/ncorp
NCI’s National Clinical Trials Network (NCTN). www.cancer.gov/research/areas/clinical-trials/nctn
Ooms J (2014) The OpenCPU system: towards a universal interface for scientific computing through separation of concerns. https://arxiv.org/abs/1406.4806
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Tangen, C., LeBlanc, M. (2020). Efficient Management of a Publicly Funded Cancer Clinical Trials Portfolio. In: Piantadosi, S., Meinert, C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_61-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_61-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering